• Home
  • About Us
    • Our Team
    • Remembering Erika
  • Our Current Focus
    • Contraceptive Choices >
      • Be Informed
      • CONTRACEPTIVE CHOICES
      • Things to Know About Contraception
      • CNN Article about Contraceptive Choices
    • Synthetic hormones
    • Video about Blood Clots
    • Video about Deep Vein Thrombosis & Pulmonary Embolisms
    • True Stories >
      • Share Your Story
    • Disinformation >
      • What Drug Reps Don't Tell Doctors
      • Drug Company Dishonesty
      • Drug Safety: Changed By One Little Sentence?
      • What Doctors Don't Know About Drugs
  • Media
    • IN THE MEDIA
    • Vanity Fair - Danger in the Ring
    • Katie Utehs/KTVU.com
    • FDA approved NuvaRing despite experts’ safety concerns
    • Marie Claire Article: Is Your Birth Control as Safe as You Think?
  • References
    • RESEARCH
    • Danish Study: NuvaRing has increased risk
    • FDA-funded Study: Increased risk of VTE with the NuvaRing
    • Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception
  • Donate
    • Donate
  • Our Team
  • About Us

Research

FDA-funded Study: “Increased risk of VTE with the NuvaRing
is new and raises concern”


The objective of this FDA-funded study was to assess cardiovascular risks, including the risk of thrombotic and thromboembolic events and death, for several newly approved products since the early 2000s that had sufficient numbers of users to allow for an evaluation of these risks compared to those associated with use of older, more frequently prescribed contraceptives at the sites selected.

The actual study, which you can read below, concludes with the following remark, “The finding of increased risk of VTE with the ETON (referring to etonogestrel in NuvaRing) vaginal ring relative to standard CHCs is new and raises concern but needs to be replicated in other studies.”

It was recognized at the time that a more in-depth assessment of potential reasons for increased risk would not be possible using only claims and electronic medical records and would require physician and patient contact, something that could be conducted later if needed.

Drug Safety and Availability > FDA-funded Study: Combined Hormonal Contraceptives (CHCs) and the Risk of Thromboembolism and Other Cardiovascular Events





IMPORTANT: 
Information shared on this website is intended to
enhance (not replace!) discussions with your doctor and other health care providers.